Page 162 - 《精细化工》2020年第9期

·1876· 精细化工 FINE CHEMICALS 第 37 卷

图 9 磺胺二甲嘧啶（a）、对羟基苯甲酸（b）、磺胺二甲嘧啶摩尔分数分别为：0.21（c）、0.58（d）、0.78（e）固相的
SEM 图
Fig. 9 SEM images of SFZ (a), HBA (b), samples with SFZ molar fractions of 0.21 (c), 0.58 (d) and 0.78 (e)

综上所述，磺胺二甲嘧啶-对羟基苯甲酸共晶的 Crystal Growth &Design, 2014, 14(9): 4475-4486.
[5] CHILDS S L, KANDI P, LINGIREDDY S R, et al. Formulation of a
XRD 特征峰出现在 9.7°、13.9°、14.8°、16.4°、18.9°、
danazol cocrystal with controlled supersaturation plays an essential
22.4°、26.9°处，DSC 熔点在 220.51 ℃和 221.69 ℃ role in improving bioavailability[J]. Molecular Pharmaceutics, 2013,
附近，SEM 图中共晶的形貌为棒状。 10(8): 3112-3127.
[6] TAO Q, CHEN J M, MA L, et al. Phenazopyridine cocrystal and
3 结论 salts that exhibit enhanced solubility and stability[J]. Crystal Growth
&Design, 2012, 12: 3144-3152.
[7] GAO Y (高缘), ZU H (祖卉), ZHANG J J (张建军). Research
（1）采用 HPLC 法同时测定溶液中磺胺二甲嘧
progress in drug co-crystals[J]. Progress in Chemistry (化学进展),
啶和对羟基苯甲酸含量的条件为：乙腈-磷酸水溶液 2010, 22(5): 829-836.
（体积比为 18∶82）为流动相，其中磷酸水溶液的 [8] BRITTAIN H G. Cocrystal systems of pharmaceutical interest:
2010[J]. Crystal Growth &Design, 2012, 12(2): 1046-1054.
pH 为 3.15，流速为 1.25 mL/min。该法能使磺胺二
[9] BRITTAIN H G. Cocrystal systems of pharmaceutical interest:
甲嘧啶和对羟基苯甲酸在 9 min 内迅速分离，在 2010[J]. Crystal Growth & Design, 2012, 12(11): 5823-5832.
1~140 mg/L 范围内线性关系良好，且分离度高，峰 [10] KARAGIANNI A, MALAMATARI M, KACHRIMANIS K.
Pharmaceutical cocrystals: New solid phase modification approaches
形良好。该法精密度和稳定性高，回收率良好。
for the formulation of APIs[J]. Pharmaceutics, 2018, 10(1): 18.
（2）采用此法测定了磺胺二甲嘧啶和对羟基苯 [11] SCHULTHEISS N C, BETHUNE S J. Pterostilbene cocrystals:
甲酸在丙酮、正丙醇、乙醇、氯仿、甲醇和乙腈溶 US8415507[P]. 2013-08-20.
[12] SUN X W, YIN Q X, DING S P, et al. Solid-liquid phase equilibrium
剂中的溶解性，选定乙腈溶剂为相图测定的合适溶
and ternary phase diagrams of ibuprofen-nicotinamide cocrystals in
剂。测定了磺胺二甲嘧啶-对羟基苯甲酸-乙腈三元 ethanol and ethanol/water mixtures at 298.15 and 313.15 K[J].
体系分别在 298.15 K 和 303.15 K 时的溶解度数据， Journal of Chemical & Engineering Data, 2015, 60(4): 1166-1172.
并绘制了对应的三元相图。对在 298.15 K 时的部分 [13] LEE K S, KIM K J, ULRICH J. Formation of salicylic acid/4,
4′-dipyridyl cocrystals based on the ternary phase diagram[J].
固相进行 XRD、DSC、SEM 表征。结果表明，随着 Chemical Engineering & Technology, 2015, 38(6): 1073-1080.
温度的升高，磺胺二甲嘧啶-对羟基苯甲酸共晶三元 [14] YAMAZAKI M, KAKEYA N, MORISHITA T, et al. Biological
相图的平衡液相线下移，不饱和区域及共晶区域增 activity of drugs. Relation of structure to the bacteriostatic activity of
sulfonamides[J]. Chem Pharm Bull, 1970, 18(4): 702-707.
大，升温有利于共晶的制备，且得到的相图是对称 [15] GHOSH S, BAG P P, REDDY C M. Co-crystals of sulfamethazine
相图，有利于共晶体的制备。 with some carboxylic acids and amides: Co-former assisted
tautomerism in an active pharmaceutical ingredient and hydrogen
参考文献： bond competition study[J]. Crystal Growth & Design, 2011, 11(8):
3489-3503.
[1] NAJAR A A, AZIM Y. Pharmaceutical cocrystals a new paradigm of
crystal engineering[J]. Journal of the Indian Institute of Science, [16] LIU W J, GUO Y J, CHEN J X, et al. Measurement and correlation
2014, 94(1): 45-67. of the solubility of telmisartan (Form A) in nine different solvents
[2] LIPINSK C A, LOMBARDO F, DOMINY B W, et al. Experimental from 277. 85 to 338. 35 K[J]. Journal of Solution Chemistry, 2016,
and computational approaches to estimate solubility and permeability 45(6): 932-946.
in drug discovery and development settings[J]. Advanced Drug [17] SUN X W (孙晓伟). Thermodynamic phase diagram and dissolution
Delivery Reviews, 1997, 23: 3-25. behavior of drug cocrystal[D]. Tianjin: Tianjin University (天津大
[3] LOFTSSON T, BREWSTER M E. Pharmaceutical applications of 学), 2015.
cyclodextrins: Basic science and product development[J]. Journal of [18] ZHANG J Y (张金彦), KUANG W J (匡雯婕), JI S C (吉绍长).
Pharmacy and Pharmacology, 2010, 62: 1607-1621. Determination of solubility and ternary phase diagram of
[4] SUGANDHA K, KAITY S, MUKHERJEE, et al. Solubility lamotrigine-phthalimide drug cocrystal in organic solvents[J]. CIESC
enhancement of ezetimibe by a cocrystal engineering technique[J]. Journal (化工学报), 2019, 70(11): 4153-4161.